Regidor, P., & Sailer, M. Open prospective study to evaluate the efficacy of a new vaginal pessary containing 300mg tinidazole, 200mg tioconazole and 100mg lidocaine with a 3-day regime (Gynomax XL®) in the treatment of vaginal infections due to bacterial vaginosis, candidiasis an. Publishing House TRILIST.
Chicago Style (17th ed.) CitationRegidor, P.A, and M. Sailer. Open Prospective Study to Evaluate the Efficacy of a New Vaginal Pessary Containing 300mg Tinidazole, 200mg Tioconazole and 100mg Lidocaine with a 3-day Regime (Gynomax XL®) in the Treatment of Vaginal Infections Due to Bacterial Vaginosis, Candidiasis an. Publishing House TRILIST.
MLA (9th ed.) CitationRegidor, P.A, and M. Sailer. Open Prospective Study to Evaluate the Efficacy of a New Vaginal Pessary Containing 300mg Tinidazole, 200mg Tioconazole and 100mg Lidocaine with a 3-day Regime (Gynomax XL®) in the Treatment of Vaginal Infections Due to Bacterial Vaginosis, Candidiasis an. Publishing House TRILIST.